• TGC = Tight Glycaemic Control
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Introduction
61
Critically ill patients exhibit increased gluconeogenesis, reduced insulin secretion and 62 increased insulin resistance, resulting in hyperglycemia, increased complications and 63 increased risk of death.
1--2 Studies show that glycemic control can reverse these outcomes.
2-3
64
However, intensive insulin therapy can also lead to increased hypoglycaemia and mortality.
4-5
65
Variable patient-specific levels of endogenous insulin secretion may also play a role,
66
particularly in early, acute phases of care. 5 In addition, the route used for the provision of non-diabetic individuals, 9 the incretin effect remains to be observed in a critically ill cohort.
85
Critically ill patients are fed differently, typically relying on constant enteral (EN) infusions. to the body's patient-specific ability to utilise them. Full details on this study can be obtained
108
from Chase et al. (2008) . 14 Specifically, the study inclusion required a minimum of 10 hours 109 of EN feeding, followed by at least 7 hours with EN off, and then at least 5 hours of resumed 110 feeding. Hence, only 52 of 371 SPRINT patients' data were selected based on these criteria.
111
Patients with diabetes (N=64) were also excluded due to irregularity of the incretin effect that 112 is known to occur in diabetes. or RESOURCE® Diabetic (Novartis) 16 . The nutritional compositions are given in (Table 2) . 
178
The blood glucose changes, ΔBG were also calculated similar to the ΔS I .
180
The analysis uses a 3-hour moving average to reduce the effect of measurement error, noise, (Fig. 2) . The changes in 213 (Table 3 -4) are evidenced by the bias about the equality line. (Fig. 2) shows the diversity of between t= -2 and t=+4 hour's are shown in (Fig. 4) The Bland-Altman plots of ΔS I (Fig. 3) show that the few larger outliers were diagnosed with Specifically, this analysis consists of a group selected from a general ICU cohort (see Table 1 286 with a representative mixture of typical ICU diagnostic codes) who met the criteria that 287 would enable the incretin effect to be observed in this study if the effect existed. It is not 288 designed, as a trial to guarantee representation of any specific ICU cohort in particular.
289
However, as seen in Table 1 It is generally accepted that intravenous parenteral nutrition (PN) prompts a lesser 301 endogenous insulin secretion than EN nutrition, 9 and thus may limit the incidence of 302 hypoglycaemia due to un-modelled insulin secretion. Plasma insulin responses to glucose
303
given by gastric or jejunal intubation were significantly greater than those seen after IV 
